News
21 hours ago
Immunotherapy
21 hours ago
Clinical Study
21 hours ago
Vaccine
21 hours ago
Drug Approval
22 hours ago
Financial Statement
22 hours ago
ImmunotherapyPhase 3Fast Track
22 hours ago
Clinical ResultDiagnostic ReagentsImmunotherapyClinical Study
22 hours ago
Fast TrackPhase 1Orphan DrugImmunotherapyAACR
22 hours ago
Phase 3VaccineClinical ResultPhase 2
22 hours ago
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI